Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Net Income: 2016-2024

Historic Net Income for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Dec 2024 value amounting to -$260.6 million.

  • Rhythm Pharmaceuticals' Net Income fell 21.23% to -$52.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$192.3 million, marking a year-over-year increase of 25.72%. This contributed to the annual value of -$260.6 million for FY2024, which is 41.11% down from last year.
  • According to the latest figures from FY2024, Rhythm Pharmaceuticals' Net Income is -$260.6 million, which was down 41.11% from -$184.7 million recorded in FY2023.
  • Over the past 5 years, Rhythm Pharmaceuticals' Net Income peaked at -$69.6 million during FY2021, and registered a low of -$260.6 million during FY2024.
  • Its 3-year average for Net Income is -$208.8 million, with a median of -$184.7 million in 2023.
  • Data for Rhythm Pharmaceuticals' Net Income shows a maximum YoY crashed of 160.18% (in 2022) over the last 5 years.
  • Rhythm Pharmaceuticals' Net Income (Yearly) stood at -$69.6 million in 2021, then slumped by 160.18% to -$181.1 million in 2022, then fell by 1.97% to -$184.7 million in 2023, then crashed by 41.11% to -$260.6 million in 2024.